WallStSmart

CBIZ Inc (CBZ)vsCintas Corporation (CTAS)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Cintas Corporation generates 316% more annual revenue ($11.56B vs $2.78B). CTAS leads profitability with a 17.8% profit margin vs 5.0%. CBZ appears more attractively valued with a PEG of 1.22. CTAS earns a higher WallStSmart Score of 62/100 (C+).

CBZ

Buy

61

out of 100

Grade: C+

Growth: 8.0Profit: 5.5Value: 6.0Quality: 6.0
Piotroski: 5/9Altman Z: 1.59

CTAS

Buy

62

out of 100

Grade: C+

Growth: 6.0Profit: 9.0Value: 2.7Quality: 7.0
Piotroski: 6/9Altman Z: 4.33
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CBZUndervalued (+11.6%)

Margin of Safety

+11.6%

Fair Value

$34.47

Current Price

$54.98

$20.51 discount

UndervaluedFair: $34.47Overvalued
CTASSignificantly Overvalued (-30.3%)

Margin of Safety

-30.3%

Fair Value

$153.72

Current Price

$218.07

$64.35 premium

UndervaluedFair: $153.72Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CBZ2 strengths · Avg: 9.0/10
EPS GrowthGrowth
64.1%10/10

Earnings expanding 64.1% YoY

Price/BookValuation
1.6x8/10

Reasonable price relative to book value

CTAS4 strengths · Avg: 9.3/10
Return on EquityProfitability
39.6%10/10

Every $100 of equity generates 40 in profit

Altman Z-ScoreHealth
4.3310/10

Safe zone — low bankruptcy risk

Market CapQuality
$84.30B9/10

Large-cap with strong market position

Operating MarginProfitability
24.1%8/10

Strong operational efficiency at 24.1%

Areas to Watch

CBZ3 concerns · Avg: 3.7/10
Revenue GrowthGrowth
1.2%4/10

1.2% revenue growth

Altman Z-ScoreHealth
1.594/10

Distress zone — elevated risk

Profit MarginProfitability
5.0%3/10

5.0% margin — thin

CTAS3 concerns · Avg: 2.7/10
Price/BookValuation
16.7x4/10

Trading at 16.7x book value

PEG RatioValuation
3.142/10

Expensive relative to growth rate

P/E RatioValuation
41.9x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : CBZ

The strongest argument for CBZ centers on EPS Growth, Price/Book. PEG of 1.22 suggests the stock is reasonably priced for its growth.

Bull Case : CTAS

The strongest argument for CTAS centers on Return on Equity, Altman Z-Score, Market Cap. Profitability is solid with margins at 17.8% and operating margin at 24.1%. Revenue growth of 10.9% demonstrates continued momentum.

Bear Case : CBZ

The primary concerns for CBZ are Revenue Growth, Altman Z-Score, Profit Margin.

Bear Case : CTAS

The primary concerns for CTAS are Price/Book, PEG Ratio, P/E Ratio. A P/E of 41.9x leaves little room for execution misses.

Key Dynamics to Monitor

CBZ profiles as a value stock while CTAS is a mature play — different risk/reward profiles.

CTAS carries more volatility with a beta of 0.92 — expect wider price swings.

CTAS is growing revenue faster at 10.9% — sustainability is the question.

CTAS generates stronger free cash flow (465M), providing more financial flexibility.

Bottom Line

CTAS scores higher overall (62/100 vs 61/100), backed by strong 17.8% margins and 10.9% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CBIZ Inc

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

CBIZ, Inc. provides financial, insurance and advisory services in the United States and Canada. The company is headquartered in Cleveland, Ohio.

Cintas Corporation

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Cintas Corporation is an American corporation headquartered in Cincinnati, Ohio, which provides a range of products and services to businesses including uniforms, mats, mops, cleaning and restroom supplies, first aid and safety products, fire extinguishers and testing, and safety courses.

Want to dig deeper into these stocks?